Early and frequent patient engagement in a clinical trial is instrumental in the launch of new medical products today. Early engagement not only improves and makes research studies more cost-effective, but also successfully leverages the patient perspective and improves participation by better balancing scientific objectives with patient goals.
Reaching out to patient advocacy groups is one way of involving the patient in the entire process from development to market. Involving these groups in this manner ensures better information reaches prospective participants and helps clinical trial centers build thriving patient communities.
In this webinar, the featured speakers will discuss a recent focal segmental glomerulosclerosis (FSGS) trial and the power of using patient insights when discussing patient and family burden, the likelihood of participation and the positive impact one patient’s voice had on the trial design and feasibility.
Eric Grossman, MD, FACP, Vice President & Medical Director, Clinipace
Dr. Eric Grossman is a nephrologist with more than 30 years of industry and clinical experience, including two decades designing and conducting Phase I–IV clinical studies for FDA submission and top-tier journal publication. Dr. Grossman is known for delivering results that surpass expectations — from completing high-quality studies quickly in both big and small pharma to markedly improving quality of care metrics in the outpatient dialysis unit at Bellevue Hospital in New York City.
While leading the medical arm of the organ procurement organization serving the New York City metropolitan area, Dr. Grossman increased organ recovery by 20–25 percent through a redesigning process driven by performance metrics. Although his focus is in nephrology, Dr. Grossman has the capability to conduct studies across a broad range of therapeutic areas including rare disease, cardiovascular, diabetes, urology, women’s health and oncology.Message Presenter
Keya Watkins, PMP, Vice President of Clinical Operations (Americas), Clinipace
Keya Watkins is responsible for project delivery in the US, Canada, Mexico and Latin America. Throughout her 22-year career in clinical research with reputable pharma and clinical service providers, Keya has provided oversight of multidisciplinary teams in project management, clinical monitoring and site support services. She also served as an executive in both operational and commercial roles and has been involved in several complex, global trials in various therapeutic areas and phases. As an executive, Keya has actively participated in merger and acquisition activities including due diligence actions.
Keya prides herself on building and managing high-functioning teams that deliver excellence while ultimately bringing meaningful therapies to patients in need. Previously, she served as senior vice president of clinical services at WIRB-Copernicus Group, senior vice president at ePharmaSolutions and executive vice president of clinical development at Omnicare Clinical Research.Message Presenter
Who Should Attend?
Senior professionals from pharmaceutical, biotechnology, medical device & diagnostics companies involved in:
- Regulatory affairs
- Strategic development
- Marketing and commercialization
What You Will Learn
In this webinar, participants will learn about the positive impact of patient insights on:
- Patient and family burden
- The likelihood of participation
- Trial design and feasibility
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach.